首页 › 非小细胞肺癌 › 伊利诺伊州 › Waukegan
Waukegan IL 非小细胞肺癌临床试验
16项针对 非小细胞肺癌的研究正在 Waukegan及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- AMG Libertyville - Oncology, Libertyville · 距离 8 英里
- Condell Memorial Hospital, Libertyville · 距离 8 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 距离 7 英里
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 距离 10 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- City of Hope Chicago, Zion · 距离 6 英里
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Advocate Medical Group - Libertyville Oncology, Libertyville · 距离 8 英里
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Captain James A. Lovell Federal Health Care Center, North Chicago · 距离 3 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- City of Hope® Cancer Center Chicago, Zion · 距离 6 英里
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
招募中3 期
- Research Site, Zion · 距离 6 英里
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, North Chicago · 距离 3 英里
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
招募中3 期
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 距离 7 英里
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 距离 10 英里
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
招募中3 期
- Cancer Treatment Centers of America (CTCA), Zion · 距离 6 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 距离 7 英里
- AMG Libertyville - Oncology, Libertyville · 距离 8 英里
- Condell Memorial Hospital, Libertyville · 距离 8 英里
- 以及另外 1 项
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 距离 7 英里
- AMG Libertyville - Oncology, Libertyville · 距离 8 英里
- Condell Memorial Hospital, Libertyville · 距离 8 英里
- 以及另外 1 项
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 距离 7 英里
- AMG Libertyville - Oncology, Libertyville · 距离 8 英里
- Condell Memorial Hospital, Libertyville · 距离 8 英里
- 以及另外 1 项
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 距离 7 英里
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 距离 10 英里
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
招募中2 期
- City of Hope at Chicago, Zion · 距离 6 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- AMG Libertyville - Oncology, Libertyville · 距离 8 英里
- Condell Memorial Hospital, Libertyville · 距离 8 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Waukegan的其他研究
- 肺癌16 项研究
- 乳腺癌12 项研究
- 溃疡性结肠炎7 项研究
- 肾癌（肾细胞癌）7 项研究
- 卵巢癌6 项研究
- 转移性癌症6 项研究
- 头颈鳞状细胞癌6 项研究
- 结直肠癌6 项研究
- 前列腺癌6 项研究
- 黑色素瘤5 项研究
- 急性髓系白血病5 项研究
- 克罗恩病5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。